XML 29 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Operations and Industry Segments
 6 Months Ended
Apr. 01, 2017
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
13
.   OPERATIONS AND INDUSTRY SEGMENTS
 
For management and reporting purposes, we divide our business into
two
segments: medical and custom products. This industry segment information corresponds to the markets in the United States, Canada and other countries for which we manufacture and distribute our various products.
 
The following table summarizes certain information on industry segments:
 
   
Three Months Ended
    
Six Months Ended
  
   
April 1,
    
April 2,
    
April 1,
    
April 2,
  
   
2017
    
2016
    
2017
    
2016
  
Net sales:
                                
Medical
   $
12,927,831
    $
10,972,017
    $
25,445,982
    $
22,364,814
 
Custom products
    
2,298,045
     
3,880,612
     
5,002,523
     
13,939,997
 
    $
15,225,876
    $
14,852,629
    $
30,448,505
    $
36,304,811
 
                                 
Operating profit (loss):
                                
Medical
   $
1,781,601
    $
1,229,251
    $
3,388,046
    $
2,731,102
 
Custom products
    
(76,908
 )    
154,420
     
(90,089
 )    
359,220
 
     
1,704,693
     
1,383,671
     
3,297,957
     
3,090,322
 
                                 
Corporate expense
    
(301,628
 )    
(223,481
 )    
(503,652
 )    
(373,677
 )
Other income (expense)
    
737,410
     
(53,441
 )    
771,062
     
54,856
 
Income before income taxes
   $
2,140,475
    $
1,106,749
    $
3,565,367
    $
2,771,501
 
 
 
Total sales by industry segment include sales to unaffiliated customers as reported in our consolidated statements of comprehensive income. In calculating operating profit, non-allocable general corporate expenses, interest expense, other income and income taxes are not included, but certain corporate operating expenses incurred for the benefit of both segments are included on an allocated basis.